Neurology Inpatient Clinical Education Trial

Multiple Sclerosis Clinical Trial

Official title:

Neurology Inpatient Clinical Education Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03826056
• Other study ID #: D19046
• Status: Completed
• Phase: N/A
• Start date: February 1, 2019
• Est. completion date: December 7, 2021

Study information

• Verified date: January 2021
• Source: Dartmouth-Hitchcock Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this study is to compare the effectiveness of a personalized patient education program to the current hospital education and evaluate its impact using patient satisfaction scores. The investigators hypothesize that a personalized patient education intervention will increase patient's understanding of their diagnosis and satisfaction with the care as reflected in the survey results.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 7, 2021
• Est. primary completion date: December 7, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 95 Years

Eligibility

Inclusion Criteria:

• Over the age of 18
• Must have the capacity to consent and understand the study related activities and education materials.

Exclusion Criteria:

• Under the age of 18
• Have a condition that impairs the ability to understand the study, its risks, and appropriately consent for the study

Related Conditions & MeSH terms

• Encephalitis
• Guillain-Barre Syndrome
• Headache
• Hydrocephalus
• Hydrocephalus, Normal Pressure
• Meningitis
• Multiple Sclerosis
• Myasthenia Gravis
• Normal Pressure Hydrocephalus
• Parkinsonian Disorders
• Parkinsonism
• Seizures
• Spondylosis
• Vestibular Diseases
• Vestibular Disorder

Intervention

Behavioral:
• Current standard discharge educational intervention
The patients will receive the current hospital standard discharge educational material which explains the diagnosis, new medications, follow up and any activity/diet restrictions. A member of the study team will explain this material to the patient and answer any questions.
• Personalized discharge educational intervention
The patients will receive a new personalized discharge educational material which will explain the specifics of their disorder, the treatment, and prognosis. The materials will contain simple, organized explanations and graphics. A member of the study team will explain this material to the patient and answer any questions.

Locations

Country	Name	City	State
United States	Dartmouth- Hitchcock Medical Center	Lebanon	New Hampshire

Sponsors (1)

Lead Sponsor	Collaborator
Dartmouth-Hitchcock Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient satisfaction scores	The patients will answer a survey consisting of seven multiple-choice questions regarding their perception of the education intervention. Each questions will be scored on a scale of one to four for a total possible score of 28 for all 7 questions. A score of 1 indicates a negative perception of the education whereas 4 indicates the most positive impression. Therefore the lowest possible score is 7 for a severely negative perception of the education and the highest score is 28 for a very positive impression of the education program. Only the total scores will be compared for statistical analysis. Scores from patients in the current standard and new personalized education intervention groups will be compared.	Subjects will be expected to mail the feedback forms within 2 weeks of discharge. Investigators will mail a single reminder prepaid return mail with a copy of the questionnaire to patients who do not respond within this time allowing 1 month total time.